GeneFerm Biotechnology Co., Ltd. Share Price

Equities

1796

TW0001796001

Food Processing

End-of-day quote Taipei Exchange 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
55.8 TWD +1.27% Intraday chart for GeneFerm Biotechnology Co., Ltd. +1.82% -25.10%

Financials

Sales 2022 634M 19.46M 1.62B Sales 2023 794M 24.36M 2.03B Capitalization 3.09B 94.81M 7.9B
Net income 2022 93M 2.85M 238M Net income 2023 125M 3.84M 320M EV / Sales 2022 4.5 x
Net Debt 2022 80.33M 2.47M 206M Net Debt 2023 7.29M 224K 18.65M EV / Sales 2023 3.9 x
P/E ratio 2022
30.3 x
P/E ratio 2023
24.9 x
Employees -
Yield 2022
2.24%
Yield 2023
2.68%
Free-Float 45.07%
More Fundamentals * Assessed data
Dynamic Chart
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
More news
1 day+1.27%
1 week+1.82%
Current month-13.76%
1 month+0.72%
3 months-19.13%
6 months-28.19%
Current year-25.10%
More quotes
1 week
54.00
Extreme 54
56.70
1 month
54.00
Extreme 54
70.80
Current year
53.30
Extreme 53.3
74.80
1 year
53.30
Extreme 53.3
158.50
3 years
30.70
Extreme 30.7
158.50
5 years
18.50
Extreme 18.5
158.50
10 years
18.50
Extreme 18.5
158.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 14/07/14
Director of Finance/CFO - 28/05/28
Chairman - 01/04/01
Members of the board TitleAgeSince
Director/Board Member - 14/07/14
Director/Board Member - 21/16/21
Director/Board Member 52 21/16/21
More insiders
Date Price Change Volume
26/24/26 55.8 +1.27% 49,734
25/24/25 55.1 0.00% 28,310
24/24/24 55.1 0.00% 41,656
23/24/23 55.1 +0.36% 45,177
22/24/22 54.9 +0.18% 71,707

End-of-day quote Taipei Exchange, April 26, 2024

More quotes
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.
More about the company